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Abstract
Many pathogens associated with chronic infections evolve so rapidly that strains found late in an infection have little in
common with the initial strain. This raises questions at different levels of analysis because rapid within-host evolution affects
the course of an infection, but it can also affect the possibility for natural selection to act at the between-host level. We
present a nested approach that incorporates within-host evolutionary dynamics of a rapidly mutating virus (hepatitis C
virus) targeted by a cellular cross-reactive immune response, into an epidemiological perspective. The viral trait we follow is
the replication rate of the strain initiating the infection. We find that, even for rapidly evolving viruses, the replication rate of
the initial strain has a strong effect on the fitness of an infection. Moreover, infections caused by slowly replicating viruses
have the highest infection fitness (i.e., lead to more secondary infections), but strains with higher replication rates tend to
dominate within a host in the long-term. We also study the effect of cross-reactive immunity and viral mutation rate on
infection life history traits. For instance, because of the stochastic nature of our approach, we can identify factors affecting
the outcome of the infection (acute or chronic infections). Finally, we show that anti-viral treatments modify the value of the
optimal initial replication rate and that the timing of the treatment administration can have public health consequences due
to within-host evolution. Our results support the idea that natural selection can act on the replication rate of rapidly
evolving viruses at the between-host level. It also provides a mechanistic description of within-host constraints, such as
cross-reactive immunity, and shows how these constraints affect the infection fitness. This model raises questions that can
be tested experimentally and underlines the necessity to consider the evolution of quantitative traits to understand the
outcome and the fitness of an infection.
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Introduction
Rapidly mutating viruses, such as hepatitis C (HCV) and
Human immunodeficiency virus (HIV), are very successful at
surviving in their hosts because of their rapid evolutionary
dynamics, which allow them to evade the immune response.
Models have been developed in evolutionary epidemiology that
link within- and between-host dynamics [1–8]. One of the main
results of these so-called ‘nested models’ is to show that
intermediate replication rates maximise the fitness of an infection
(which is known in epidemiology as the R0 and corresponds to the
number of new infections caused by an infected host in a
susceptible population [9]). However, none of these models take
into account within-host evolution. Here, we allow for the
replication rate to evolve during the course of an infection and
derive the invasion fitness of a rapidly mutating pathogen. In this
study, we focus on the case of HCV.
Modelling within-host evolution
Most theoretical and experimental studies focus on the dynamics
of viral diversity during an infection (see e.g., [10–14]) or on
qualitative traits such as drug resistance [15–17]. Studies rarely
consider quantitative traits, even though viral replication seems to
provide an exception. Variable polymerase activities have been
observed during HCV infections along withthe individual viral sub-
populations, both between infected individuals and within an
individual [18], which suggests that strain distribution in a given
host is characterised by a range of replication rates. Given the high
evolutionary rates of rapidly mutating viruses [19,20] and the
extreme selection pressure exerted by the immune response [15,21],
one can expectsuchquantitative traits to evolve during an infection.
Infections causedbyarapidlymutatingvirusexhibit high levels of
genetic diversity. Classical theory predicts that, in such a case, faster
replicating strains have the highest infection fitness because they
gather more resources before the end of the infection [22,23], which
has been confirmed experimentally (e.g., [24]). This ‘short-sighted’
evolution, with the subsequent selection of faster replicating strains,
has been proposed as a mechanism to explain HIV virulence [23].
Yet,not allstrainshavehighreplication ratesandrapidlyreplicating
strains also kill their host quickly, thus potentially decreasing their
fitness at the between-host level [25–27].
Some within-host models study the evolutionary dynamics of
the replication rate during the course of an infection. A common
finding of such models is that the replication rate increases during
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or because of apparent competition through the immune system
[28–30]. If within-host trade-offs are assumed, strains with
intermediate or low replication rates can take over the infection
[31–35].
Here, we focus on the fitness of a viral strategy at the between-
host level (i.e., how many new infections an infection can cause).
Bonhoeffer and Nowak [25] developed one of the few evolutionary
epidemiology models that includes within-host evolution of the
replication rate, however they simplified within-host processes to
the extreme by assuming that, within a host, a more virulent
mutant always instantaneously takes over the infection. Our model
describes the within-host dynamics, which allows us to follow the
evolution of the virus along with the changes in its environment
(i.e., the immune response).
Immune activation as a constraint
The immune system is known to be a major constraint on viral
evolution [21,36]. This underlines the importance of including
immune dynamics in within-host models [37,38]. Following [7],
we assume that immune activation depends on the overall viral
growth rate, i.e., the product of the viral replication rate and
density. The idea underlying this assumption is that increasing the
growth rate can be detrimental for the virus because it increases
immune pressure. An implication of such a trade-off is that a strain
with a lower growth rate can have higher infection fitness because
the infection lasts longer.
This assumption echoes the immunogenicity criterion formal-
ised by Pradeu and Carosella [39]: maintaining a continuity,i n
terms of antigens (viral peptides recognised by the immune system)
present in the host, can be decisive for the pathogen to avoid
triggering an immune response. How can the replication rate
affect this continuity? Infected cells process and present antigenic
peptides, that are ‘pictures’ of the current intracellular state, to the
initial T-cell repertoire. Yewdell [40] argues that there is a clear
link between viral translation (i.e., the production of non-
endogenous proteins) and antigen presentation. The reason for
this is that rapidly degraded polypeptides (associated with rapid
translation) lead to a more efficient generation of major
histocompatibility complex (MHC) Class-I peptides, which are
then presented to cytotoxic T cells. This explains why infected cells
can be identified so rapidly: viral peptides have a higher chance to
be expressed than endogenous peptides because they are degraded
more rapidly than endogenous gene products [40]. Rapidly
replicating viruses could then be an easy target for the immune
system if they generate a larger pool of rapidly degraded
polypeptides. This is consistent with the fact that 2,000 to
10,000 copies of a protein are needed for successful processing and
presentation of MHC Class I peptides [41]. A few experimental
studies have also shown that increasing the viral replication rate
provides a wider and more abundant antigen presentation
[40,42,43]. One must admit that it is difficult to disentangle the
roles of variations in replication rates and variations in viral
density because the two are obviously linked [7]. Moreover, many
other factors such as the dose, the localisation and the duration of
antigen presence are also critical to immune activation [44].
Here, we develop a nested model that links within-host
evolutionary dynamics to the epidemiology. By explicitly describ-
ing the immune dynamics, the model takes into account the fact
that a viral strategy dominant early in an infection (e.g., replicating
slowly to escape the immune system) may be rare later in the
infection.
Results
We perform stochastic simulations with a model that describes
the within-host evolution of a viral strain undergoing mutation. In
our model, the immune response is assumed to be strain specific
and we account for cross-reactive immunity, i.e., the fact that
strains are recognised by more than one clone of lymphocytes.
Viral strains are identified by their replication rate and their
antigen value, the latter defining the extent to which the strain is
recognised by a given T-cell clone. We introduce between-host
dynamics by adding transmission events whose probabilities
depend on the viral load at a given time (see the Model section
and Table 1 for a description of the variables and parameters
used).
Figure 1 shows the outcome of two ‘typical’ stochastic
realisations of the within-host evolutionary dynamics performed
with default parameter values. The first result is that the exact
same parameter values can lead to a chronic (A, C and E) or an
acute (B, D and F) infection. Panel A shows that both the viral load
and the number of immune cells vary strongly during the early
phase of the infection, which is consistent with observations from
several chronic infections (e.g., [45]). Also, the increase in the
number of immune cells and infected cells occurs two weeks after
the beginning of the infection, which is in line with clinical
observations [46]. In chronic infections, the overall density of
immune cells increases slightly (Figure 1A), which is likely to be
linked with the increase in the average virus replication rate (see
below). Longitudinal analyses of cellular immune responses to
HCV in chimpanzees and humans, although limited to small
sample sizes, show that immune responses may persist during the
chronic phase and eventually stabilise to levels that depend on host
immunity and on the viral strain [47,48]. Panels C and D show
that diversity increases rapidly within a few days. In the case of
chronic infections (Figure 1C), diversity reaches a threshold. This
mutation-selection equilibrium is constrained by the fact that the
antigenic space is finite. Panels E and F show that there is also
diversity in viral replication rates and that, for these parameter
values, the average replication rate tends to increase during the
infection. This increase is a result of the apparent competition
generated by the cross-reactive immune response (see also [8]).
Author Summary
Rapidly mutating viruses, such as hepatitis C virus, can
escape host immunity by generating new strains that
avoid the immune system. Existing data support the idea
that such within-host evolution affects the outcome of the
infection. Few theoretical models address this question
and most follow viral diversity or qualitative traits, such as
drug resistance. Here, we study the evolution of two virus
quantitative traits—the replication rate and the ability to
be recognised by the immune response—during an
infection. We develop an epidemiological framework
where transmission events are driven by within-host
dynamics. We find that the replication rate of the virus
that initially infects the host has a strong influence on the
epidemiological success of the disease. Furthermore, we
show that the cross-reactive immune response is key to
determining the outcome of the infection (acute or
chronic). Finally, we show that the timing of the start of
an anti-viral treatment has a strong effect on viral
evolution, which impacts the efficiency of the treatment.
Our analysis suggests a new mechanism to explain
infection outcomes and proposes testable predictions that
can drive future experimental approaches.
HCV Evolution within and between Hosts
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dynamics of disease transmission. On panels E and F, large blue
dots indicate strains that are transmitted following a stochastic
transmission event (see the Model section). Given their longer
duration, chronic infections lead to more transmission events than
acute infections. More importantly, viruses transmitted from
chronic infections tend to have higher replication rates due to
within-host evolution (Figures 1E, 1F and S2), which could affect
the epidemiological dynamics. In our approach, this effect will be
averaged because we do not model the timing of transmission
explicitly.
To get a more accurate picture of the evolutionary dynamics, we
performed multiple runs of simulations with different parameter
values. Table 2 summarises the effects we observe on infection life-
history traits when varying parameters or initial values. Results are
based ona linear fitusinga multivariatelinearmodel onthedata we
obtain (see Text S1 for further details on the simulations and on the
statistical tests). Figure 2 shows the effect on infection life-history
traits of variations in the initial replication rate (on the horizontal
axis) and for different intensities of cross-reactive immunity (the
different curves). The case with default parameter values (used for
Figure 1) is shown with black filled circles.
Role of the initial replication rate
As described in the Model section, in order to show that natural
selection can act on the replication rate of the infecting strain at
the epidemiological level, we need to show that this trait affects
infection fitness and is heritable from one infection to the next. In
this subsection, we focus on the default case (in black in Figure 2).
We find that the initial replication rate (Q0) has a strong effect
on infection fitness, which is maximised for low replication rates
(Figure 2A). The fact that very low or high values of Q0 lead to low
fitness values is likely to be due to short duration of the infections
(Figure 2B). This is also clear from the statistically significant
correlations we observe between the infection fitness and the initial
replication rate (Table 2). Note that the value of Q0 maximising
the infection fitness depends on the base-line clearance term of
infected cells (dx, figure not shown). The correlation between Q0
and the average replication rate of transmitted strains (Figure 2C)
suggests that the trait is heritable. For low values of Q0, transmitted
values can be higher than Q0 (Figure 2C) because the trait evolves
for a longer time within the host (Figure 2B). Also, viral diversity
increases as the infection progresses (Figure 1C), implying that the
distribution of transmitted replication rates also changes over time
(see Figure S1). According to these results, predictions are more
complex to achieve for long-lasting infections and call for an
explicit epidemiological model based on the distribution of
transmitted strains resulting from the within-host dynamics.
Figure 2D shows that viral diversity near the end of the infection
is maximised for low replication rates, which is likely to be due to
an increased duration of the infection (Figure 2B). The density of
infected cells near the end of the infection also has a maximum
value for low replication rates (figure not shown). Finally, higher
initial replication rates always lead to higher final levels of immune
cells densities (Table 2). These results suggest that for low
replication rates, infections are long lasting (most of the simulations
end because the maximum time of 800 days is reached) whereas
for other values the infection is often cleared by the immune
response. Overall, the initial replication rate significantly influ-
ences the course of the infection.
Role of cross-reactive immunity
We model the variation in the breadth of the immune response
by varying the width (q) of the cross-reactive immunity function in
Table 1. List of the variables and parameters of the model.
Notation Description Value
xi Number of cells infected with viruses of strain i variable
yj Number of immune cells specific to strains with antigen Aj variable
n Number of viral strains variable
m Number of lymphocyte clones 20
Qi Replication rate of viral strain i (day
21) 0:01, Wmax ½ 
c
Wmax Maximum replication rate (day{1) 4
Ai Antigen value of viruses of strain i variable
Rj Receptor value of lymphocytes of clone j variable
smax Maximum killing rate (day
21 lymphocyte
21) 10{5
cmax Maximum activation rate of lymphocytes (infected cells
21) 10{5
q Breadth of immune cells specificity 0:1
m Virus mutation rate (per generation) 10{5
w Width of the distribution of replication rates 0:1
dx death rate of infected cells (day
21) 0:2a,b
dy death rate of lymphocytes (day
21) 0:05a,c
r Probability of transmission to another host (per generation) 0:005
g Probability of virulence, i.e. host death (per generation) 0
t1 Intensity of a virus-clearance treatment (day
21)0
t2 Intensity of a replication-blocking treatment (day
21)0
Ranges for parameter values for the death rates and for the killing rate are taken from a [82], b [51], c [42] and d [83].
doi:10.1371/journal.pcbi.1000565.t001
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PLoS Computational Biology | www.ploscompbiol.org 3 November 2009 | Volume 5 | Issue 11 | e1000565Figure 1. Within-host population dynamics and evolutionary dynamics for two ‘‘typical’’ simulation runs. With identical parameter
values, we can observe a chronic (A,C,E) or an acute (B, D, F) infection. A) and B) Population dynamics of infected cells (in black) and immune cells (in
red). C) and D) Diversity dynamics (Shannon index). E) and F) Evolutionary dynamics of the replication rate. Black dots indicate the replication rates
present at any time, the red line is the average replication rate for each time t, and the large blue dots show the replication rates of the strains that
are transmitted to another host after a transmission event. Here Q0~0:5. Other parameter values are default and given in Table 1.
doi:10.1371/journal.pcbi.1000565.g001
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(q) reduces infection fitness (Figure 2A and Table 2) and decreases
viral diversity near the end of the infection (Figure 2D). The
decrease in fitness seems to be due to a decrease in the duration of
the infection (Figure 2B). Increasing cross-reactive immunity (q)
also decreases the replication rate of transmitted strains
(Figure 2C). This result, which may seem counter-intuitive, is a
consequence of the stochastic nature of our simulations. Increasing
q increases the rate of immune activation, which limits the
opportunities for escape mutations and thus decreases the duration
of the infection (Figure 2B). In our model, however, the activation
rate of immune cells depends on the replication rate of the virus.
Therefore, an increase in immune pressure confers a strong
selective advantage to slow-replicating strains.
In the case of infections caused by a rapidly replicating strain
(high Q0), there are two scenarios: rapid clearance or rapid
evolution towards lower replication rates. The latter prolongs the
infection and the number of transmission events, thus decreasing
the average value of replication rates of transmitted strains. Unless
cross-reactive immunity is very high, diversity near the end of the
infection is maximised for low values of the initial replication rates
(Figure 2D). Overall, cross-reactive immunity significantly de-
creases infection fitness and within-host evolution, and alters the
strain composition and therefore the transmission dynamics.
Role of the mutation process
We model viral mutation as a stochastic process (see the Model
section and Text S1). A newly generated strain is identified by at least
one new trait value (its replication rate and/or its antigenic value). We
study the effect of the mutation process on infection life-history traits.
Overall, there is no substantial effect of the mutation rate (m)o nv i r a l
fitness, which has a maximum value for low values of the initial
replication rate (Figure 3A). However, increasing m tends to be slightly
deleterious in terms of infection fitness for strains with low Q0 because,
with high m, rapidly replicating mutants tend to appear earlier, which
decreases the duration of the infection. For high values of Q0,h o w e v e r ,
increasing the viral mutation rate leads to an increase in viral fitness
because mutation rate increases the probability that an escape mutant
is generated before the first infecting strain is cleared. The mutation
rate also significantly correlates with the duration of the infection, the
final level of viral diversity and the average replication rate of
transmitted strains (see Table 2 and Supporting Figure S2).
Increasing the width (w) of the uniform distribution from which new
mutant replication rates are chosen decreases infection fitness and
increases both the duration of the infection and the initial replication
rate that maximises fitness (Figure 3B and Table 2). Also, increasing w
leads to a significant increase in average replication rate of transmitted
strains (Figure S2) and to a decrease in final viral diversity (Table 2).
Contrary to the mutation rate, increasing the width w does not increase
the probability that an escape mutation is generated by the initial
s t r a i n .H o w e v e r ,f o rh i g hv a l u e so fw, rapidly-replicating mutants
appear early in the infection. Since these mutants are more adapted to
the apparent competition taking place at the within-host level (see the
Discussion), increasing w decreases the infection diversity and fitness for
low values of Q0. From a biological point of view, increasing the size of
the mutation step can be interpreted as the introduction of
recombination between unrelated strains. This process is rare for
HCV, but it has been shown to occur within some hosts [49].
Role of immune system activation and killing rates
Increasing the maximum T-cell activation rate (cmax) improves
the immune response, therefore the consequences of an increase in
cmax are not surprising: it significantly decreases infection fitness
(Figure 3C), duration of the infection, final diversity and final total
viral load (Table 2). Also, the initial replication rate that maximises
infection fitness increases with cmax, which is consistent with
earlier models without within-host evolution [5]. For large values
of cmax infections tend to be very short and there is no heritability
of the trait (see Figure S2).
Increasing the maximum T-cell killing rate (smax) also increases
the efficiency of the immune response but the evolutionary
response seems to differ with respect to variations of cmax
Table 2. Influence of model parameters and of the initial replication rate on infection life-history traits.
Parameters -----------
Traits
Initial replication
rate (Q Q0)
Cross-reactive
immunity (q)
Maximum immune
activation rate (cmax)
Mutation
rate (m)
Mutation
width of Q Q (w)
Maximum killing
rate (smax)
Treatment
intensity (t2)
Infection fitness Y
&    Y
    Y
   X
  Y
  X
    Y
  
X
&&   
Duration of the
infection (Log)
Y
&    Y
    Y
    X
    X
    X
    Y
   
X
&&   
Mean replication rate of
transmitted strains
X
    Y
    Y
    X
    X
    X
    Y
n:s:
Final viral diversity Y
&    Y
    Y
    X
    Y
    X
    Y
  
X
&&   
Final number of
immune cells (Log)
X
    Y
  Y
  X
  X
    Y
    Y
   
Final number of i
nfected cells (Log)
X
    Y
n:s: Y
    Y
  Y
   X
n:s: Y
   
We performed linear fits based on a multivariate linear model on the mean values of the traits as a function of 12 factors: 9 model parameters (q, m, smax, cmax, t1, t2, g,
w, r), the initial replication rate Q0, the initial number of precursor of lymphocytes (y0), and the initial number of infected cells (x0). Further details about the statistical
tests are available in Text S1. Significance level a~0:01.
Significance test codes: ‘
***’: 0:001;‘
**’: 0.01; ‘
*’: 0.05; ‘
n.s.’: non significant.
&Test performed conditioning on Q0w0:2.
&&Test performed conditioning on Q0ƒ0:2.
doi:10.1371/journal.pcbi.1000565.t002
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fitness of rapidly replicating strains and the duration of the
infections these strains cause (Table 2). Indeed, the increase in
smax leads to a decrease in the number of infected cells early in the
infection. Since immune activation is proportional to the number
of infected cells present in the system, the increase in killing
capacity also has a drawback: it slows down the immune response.
Therefore, both the duration of the infection and the viral density
increase, thus improving the infection fitness. When the killing rate
is very high, the virus is completely eliminated and no within-host
evolution occurs. Overall, these results show that interfering with
immune activation or immune killing can lead to different
outcomes. Also, the result that increasing immune response does
not always reduce viral fitness is in accordance to the experimental
observation that HCV generates a highly cytotoxic environment
and therefore it is the immune response that may jeopardise host
survival. Our model thus provides a simple mechanism that
explains how an increase in immune resources can limit the
immune response.
We also studied the effect of the initial population sizes of
infected cells and of lymphocytes (precursor frequency), the
possibility of host death (i.e., virulence) and of saturation in the
lymphocyte proliferation function in equation 1. These results are
shown in Text S2.
Long-term optimal replication rate
In the absence of within-host evolution, Figure 2A would be
sufficient to infer the evolutionary stable strategy (ESS, [50]) of the
virus, i.e., the replication rate that is selected on the long term. In a
model with within-host evolution where all infections would
produce the same number of secondary infections (i.e., have the
same infection fitness), Figure 2C could be used to find the ESS.
The latter, if it exists, is at the intersection between the curve and
the y~x line (see the caption of Figure 4 for further details).
Figure 2. Effect of the variation of the initial replication rate (Q Q0) and of the breadth of cross-reactive immunity (q) on infection life-
history traits. A) Number of transmission events (i.e. infection fitness), B) Duration of the infection, C) Average replication rate of transmitted strains,
and D) Viral diversity (Shannon index) near the end of the infection. Curves with different colour symbols represent simulations performed with
different values of q (see the box in panel A). The case with default parameter values is shown with black filled circles. For further details about the
simulations see the main text and Text S1.
doi:10.1371/journal.pcbi.1000565.g002
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can be evolutionary stable (i.e., be an ESS) or unstable: if the curve
intersects the y~x line from top to bottom (i.e. that it is concave),
there is an ESS.
In our model, each one of the transmitted strains potentially has
a different infection fitness based on its replication rate. We
therefore combine differential fitness (Figure 2A) and within-host
evolution (Figure 2C) to identify the ESS (see Model Section).
Figure 4 shows the average replication rate of transmitted strains
weighted by their infection fitness for different values of q. In the
default case, the ESS is obtained for Q &1 (the black star in
Figure 4). This estimate is close to what would be obtained by
ignoring the differences in infection fitness, which indicates that
within-host evolution acts more strongly than between-host
evolution. Increasing the level of cross-reactive immunity favours
those strains with higher replication rates, which eventually
dominate the population on the long term. For low values of q,
curves in Figure 4 strongly differ from those in Figure 2C. This
shows that the control over trait evolution can shift from the
within-host to the between-host level when parameter values
change.
Effect of treatments on viral evolution
We simulate two types of treatments: the first type improves the
killing of infected cells and is modelled with an additional killing
term of infected cells, the second type blocks viral replication and
is modelled with a limitation term on viral replication. Current
treatments of HCV use interferon-a typically in combination with
ribavirin. These treatments act on viral dynamics by blocking viral
replication [51], but also stimulate innate and cellular immunity
[52,53].
In Figure 5, we show the effect of a replication-blocking
treatment administered with different intensities (t2) and started at
different time points (0, 30 or 180 days after infection). A
treatment model based on increasing immune killing leads to
similar results (results not shown). This is because, in our model,
Figure 3. Effects of parameter variations on infection fitness. Effect of the initial replication rate (x-axis) on the infection fitness for different
values of A) the mutation rate m, B) the mutation width for the replication rates w, C) the maximum proliferation rate of immune cells cmax, and D) the
maximum killing rate of immune cells smax. Different parameter values are shown using different colour symbols (see the box in each panel) and the
default case is in black. For further details about the simulations see the main text and Text S1.
doi:10.1371/journal.pcbi.1000565.g003
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PLoS Computational Biology | www.ploscompbiol.org 7 November 2009 | Volume 5 | Issue 11 | e1000565there is only immune-mediated competition between strains and
no resource competition. Overall, increasing t2 decreases the
infection fitness, the duration and the diversity of the infection
(Figure 5A, C and, E, and Table 2). Note that the average
infection fitness values we show in Figure 5 are obtained by
including hosts who cleared the infection before the initiation of
the treatment. Regardless of the starting time, increasing the
treatment intensity increases the value of the initial replication rate
that maximises infection fitness (Figure 5A, C and E), as in models
without within-host evolution [5].
The timing of the treatment also affects the course of an
infection. When the treatment is initiated at the onset of an
infection (which would be the case if hosts are treated following
exposure), we see a shift of the curves to the right (Figure 5A, C
and E). This means that the virus can compensate completely for
the fitness decrease due to treatment by increasing its replication
rate. The current practice in HCV infections is to treat the patient
after several months to avoid treating cases that resolve naturally,
and because treatments based on interferon-a are toxic. We show
that delaying the treatment also has an evolutionary advantage
because strains that do well in a treated host are also the strains
that tend to lead to acute infection (Figure 2B).
In order to investigate the effect of treatment at the host level
rather than at the host population level, we focussed on the
duration of the infection and removed from the analysis hosts who
had cleared the infection before the beginning of the treatment
(Fig. 5B, D and F). We find similar effects as for the infection
fitness: depending on the initial replication rate and on the
treatment intensity, the duration of the infection can decrease (e.g.,
if Q0 is low and t2 is high) but it can also increase (e.g. if Q0 is high).
The only case where the treatment always decreases the duration
of the infection is when treatment begins after 180 days (Figure 5F).
This is because in the other cases not all the acute infections have
ended and treating at that time allows rapidly-replicating strains to
persist in the host.
Discussion
We developed a nested model that incorporates within-host
evolutionary dynamics into an epidemiological perspective to
study the evolution of viral traits, such as the replication rate. This
approach raises an important issue in that viral traits evolve within
the host during the course of an infection and at the between-host
level. In other words, what infects a host (a strain with its initial
replication rate) differs from what is transmitted (a distribution of
replication rates). We show that the replication rate of the strain
that initiates the infection has a strong effect on the course and on
the fitness of an infection. On average, the initial replication rate
tends to be heritable from one infection to the next. These two
results (heritability and fitness effect) combined with the known
variability in replication rates indicate that, in our model, natural
selection acts on viral replication at the between-host level.
Slow replication maximises infection fitness
We find that infection fitness (measured as the number of
transmission events per infection) is maximised for infections
initiated by slow-replicating strains. This is partly due to the
assumption we make on the immune proliferation function, which
allows slow-replicating strains to have the most efficient resource
exploitation (by escaping from the immune response). Escaping
from the immune response has a second advantage because it gives
more opportunities to these strains to generate escape mutants. We
are not aware of studies on the evolution of HCV replication rate
at the between-host level. In the case of HIV, the subtype C of
HIV-1 has been shown to be spreading more rapidly than other
subtypes [17]. Interestingly, viruses of this subtype are out-
competed when grown with viruses from other subtypes. Even if in
vitro conditions have little in common with the within-host
environmental conditions, these results suggest that slow replica-
tion could be optimal at a population level for rapidly evolving
viruses (see also [54]).
In epidemiology, the idea that low replication rates can be
optimal is not new; it is present in the transmission-virulence trade-
off theory [55,56], which states that pathogens should spare their
host to maximise the duration of the infection. However, most
models ignore within-host evolution of the replication rate (but see
[25]). Our nested model provides an explicit description of the
within-host mechanisms that drive evolution toward low replica-
tion rates.
Our model also illustrates the conflict between levels of selection
[25–27]. At the between-host level, slow-replicating strains have
an advantage because they tend to generate longer infections, thus
leading to more transmission events. At the within-host level
however, rapid replication is favoured through cross-reactive
immunity. As discussed in [8], rapid replication leads to higher
activation of the immune response, which penalises slow-
replicators (rapid replication rate being a means to compensate
for the immune killing). Note that here, contrary to other models,
the virus cannot indefinitely evolve to higher replication rates
within the host because the immune activation function depends
on both viral density and viral replication rate [7]. This explains
why, for default parameter values, strains with a replication rate
close to 1 are likely to dominate the population over the long term
even though the highest infection fitness is reached for replication
Figure 4. Weighted average replication rate of transmitted
strains for different values of cross-reactive immunity (q). This
figure is obtained by combining Figures 2A and 2C (see the main text).
The average replication rates are weighted with the infection fitness
values (see Figure 2A). Long-term optimal replication rates are indicated
with stars, which are located at the intersection between the curves and
the y~x line. Intuitively, if the transmitted replication rate is above the
y~x line, the virus evolves towards higher replication rates, whereas if
the transmitted replication rate is below the line, the virus evolves
towards lower replication rates. Only if the transmitted replication rate
is on the line do we have an evolutionarily singular strategy. Increasing
cross-reactive immunity decreases the long-term optimal replication
rate.
doi:10.1371/journal.pcbi.1000565.g004
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PLoS Computational Biology | www.ploscompbiol.org 8 November 2009 | Volume 5 | Issue 11 | e1000565Figure 5. Effect of the timing and of the intensity of anti-viral treatments limiting viral replication. In panels A, and B the treatment
starts at the time of the infection, in panels C, and D the treatment starts 30 days after the beginning of the infection. Finally in panels E and F
treatment starts 180 days after the infection. Panels A, C, and E show the average infection fitness (IF). Panels B, D, and F show the average duration of
the infections (DoI). The latter is calculated by excluding simulation runs that result in host before the beginning of the treatment (this is done to
highlight the effect of the treatment at the within-host level). Different colours correspond to different treatment intensities (t2, see legend in panels
C and D). The default case is in black. Note that in panel F, infections starting with low replication rates are cleared before treatment is initiated. For
further details about the simulations see the main text and the Text S1.
doi:10.1371/journal.pcbi.1000565.g005
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favours more slowly replicating strains in the long term at the
between-host level. This effect is much clearer at the between-host
level (Figure 4) than at the within-host level (Figure 2A), and also
highlights the fact that changes in within-host parameter values
can shift the overall selective pressure from the within-host to the
between-host level.
Importance of the timing of treatments
Our model allows us to study the evolutionary consequences of
anti-viral treatments on infection life-history traits. Increasing the
efficiency with which a treatment blocks viral replication decreases
viral fitness, but also increases the evolutionarily optimal
replication rate of the virus. This is consistent with theoretical
[57,58] and experimental results [59]: treatments decrease viral
fitness but they also select for more virulent parasites.
Most epidemiological models find a host ‘selfish’ strategy, which
consists in increasing its own protection at the expenses of the
community [57]. Here, starting a treatment is not always the best
option for the host because, in addition to the toxicity of the drugs,
treatment can increase the duration of the infection. This is
especially true for acute HCV infections, where hosts recover
without intervention. Therefore, we stress the importance of a
neglected factor in evolutionary epidemiology, i.e., the timing of
treatment administration. We show that administering treatment a
few months after the infection begins, imposes a treatment-free
period that selects against rapidly replicating strains. Of course,
this procedure is acceptable only if the short duration of the
infection comes from rapid host clearance and not from host death
(fortunately, acute HCV infection very rarely results in fulminant
disease). These predictions could be tested empirically by
comparing the course of the infection in patients infected by
similar HCV genotypes for whom treatment started at different
time points.
Viral evolution and disease outcome
Few studies have attempted to model HCV disease outcomes.
Wodarz [60] studied the pathology of HCV with a multi-strain
model that described both cellular and humoral immune
responses. However, this model did not account for antigenic
diversity nor for different viral traits. Population genetics and
phylogenetic analysis applied to HCV provide evidence that HCV
evolution within-host is under a strong immune pressure [61] and
that disease outcome is statistically associated with the number of
genetic sites selected [62].
A key feature of our model is that for the exact same parameter
values, we can observe chronic or acute infections (for a review on
this topic, see [63]). In both cases there is a significant amount of
viral diversity generated, which means that this result is not only
due to the fact that fewer escape mutants are generated during
acute infection outcomes. Finally, we find that there is a delay of a
few weeks in launching a specific immune response following viral
infection, which is consistent to reports in acute HCV infections.
This also echoes a more general concern about most within-host
models, in which the outcome of the infection tends to be an
assumption rather than a result [38].
We show that replication rate of the initial strain and the
parameters describing the immune response alter the probability
that one of the two outcomes (chronic or acute infection) is
reached. The few observations on the correlations between the
outcome of HCV infections and the viral replication rate tend to
support our results. Data on the growth of HCV in sera suggest
that slow replicating viral populations are common in HCV cases
with viral persistence [64–66]. A direct relationship between the
initial viral replication kinetics and cellular responses has also been
observed [46]. Moreover, a study based on a peculiar sample of
seven people infected on the same day from the same source
showed a correlation between viral load and the dominance of a
few strains [67]. They also showed that subjects with lower viral
loads had a higher diversity that increased over time, thus
suggesting an evolutionary process driven by slow-replicating
strains, which fits with our result that these strains have the highest
infection fitness.
The immune response against HCV is puzzling. The mecha-
nisms responsible for the high rate of viral persistence are thought
to be the result of complex early host-virus interactions that
involve immune system heterogeneity, viral diversity and cross-
reactive immunity [63,68]. In acute HCV infection there is a
significantly broader cytotoxic T-cell response with wider variant
cross-recognition capacity than in chronic cases [69]. A significant
result of our work is that cross-reactive immunity decreases viral
diversity, and infection fitness, thus supporting the idea that viruses
face a trade-off: low replication maximises infection fitness but
rapid replication helps to escape from cross-reactive immunity.
However, one needs to be careful about drawing conclusions from
our model regarding the optimal level of cross-reactivity of the
immune response, as increasing the width of the cross-reactive
immunity function confers a cost-free advantage to the immune
system. Therefore, it should not come as a surprise that infection
fitness decreases with cross-reactive immunity. A more detailed
analysis should introduce a cost to the breadth of the immune
response (for instance in terms of efficiency of killing).
Perspectives
The between-host dynamics of our model could be extended in
several ways. We used an invasion fitness analysis (with R0), which
simplifies the analysis but can also be misleading [70]. Adding a
detailed between-host framework would allow to remove the
assumption that the size of the susceptible host population remains
constant and would lead to more accurate epidemiological
dynamics.
Modelling the between-host dynamics more explicitly would
allow one to take into account the age of the infection. Day [71]
shows that variations in transmission rates during the infection
(which is likely to happen if parasite densities vary) can affect the
epidemiology of the disease. Here, as we show in Figures 1E and
S2, the trait of the transmitted strains varies over the duration of
the infection. This could significantly impact on the evolution of
the trait during an epidemic, for instance if rapidly replicating
strains are transmitted later in the infection (see [6] for a similar
discussion in a case with only two strains per host).
Another extension would be to include several transmission
routes for the virus. The model we use here assumes that infections
are initiated by a unique viral strain, which is known to be the case
for sexual transmission of HIV [72]. However, transmission can
also occur through needle sharing in which case the inoculum is
more likely to be diverse. Allowing for multiple transmission routes
would influence both the within- and between-host dynamics.
Regarding the selective forces involved in the evolution of HCV
at a population level, there is evidence that the major
histocompatibility complex (MHC) allele diversity among the
population is a major force driving the evolution of the virus [68].
Host heterogeneity could be introduced by assuming that each
host type has lymphocytes with different antigenic values for their
receptors. This would allow us to identify the optimal viral strategy
at the between-host levels for different parameter sets. It would
also allow us to further investigate the unresolved issue of why,
during HCV infection, mutants that escape the immune responses
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we suggest that this evolutionary process may be influenced by
both the antigenic value (epitope escape) and the viral replication
rate; host diversity is likely to have a strong impact as well.
Our work leads to predictions that can be tested experimentally:
strains that dominate early in the infection and those that
dominate later have different replication rates; and the replication
rate of the initial strain and the mutation rate affect the duration
and/or the fitness of an infection (see Table 2 for a summary). Of
course, some experimental difficulties need to be overcome. First,
estimating the replication rate of a circulating strain may be
challenging. Second, diversity in replication rates may be difficult
to assess if some of the circulating strains are rare. Third, in the
case of HCV, it is rare to detect the infection in the early acute
phase (as it is typically asymptomatic). Another interesting
question raised by this model that calls for empirical support is
the heritability of infection life-history traits in the case of rapidly
evolving diseases. This question has been studied in the case of
HIV virulence, but there is still no convincing evidence that this
trait is heritable from one infection to the next [54].
This study stresses the key role played by the cross-reactive
immune response in controlling the duration and the fitness of an
infection. In addition to the theoretical challenge described above,
an experimental validation of this study could be to measure ex vivo
the strain-specific immune response and the degree of cross-
reactive immunity within-host, and finally to investigate the role of
these responses in the outcome of the infection. This model
validation could be achieved by identifying strain specific and
shared T-cell responses across multiple strains during an infection.
Experimental assays such as the Elispot assay, in vitro stimulation
and intracellular cytokine detection, and MHC-tetramer staining
are established methods to measure the T-cell responses against
specific T-cell epitopes [69,73,74]. However, these assays carry a
substantial cost given the large uncertainty and variation in the
distribution of MHC class I and II epitopes between infected
individuals. Bioinformatics tools have been successfully used to
predict pools of MHC class I epitopes (which can be synthesised as
peptides) to be employed in immunological assays to measure T-
cell specific responses [75]; these predictions minimise the
experimental effort in identifying T-cell epitopes in terms of cost
and timing [76]. One could validate the model predictions by
measuring variations in viral replication rates with in vitro assays,
and of strain specific immune responses using prediction tools and
T-cell response read-out techniques, during the course of the
infection. Overall, combining bioinformatics tools, immunological
assays, and theoretical models on viral trait evolution forms a
promising framework for detecting and measuring the presence of
immune selection during the within-host evolution of rapidly
mutating viruses.
Model
Within-host dynamics
We model viral dynamics with an immune control model based
on a predator-prey-like interaction, where lymphocytes are
predators. We assume a finite number of T-cell clones per host,
m, while the number of viral strains, n, varies during the infection.
We explicitly take into account the cross-reactivity of the immune
response i.e., the fact that a lymphocyte clone can be activated by
and destroy more than one viral strain.
Following previous models, we simplify the virus life cycle by
focusing on infected cells only [37,38]. The reason for this is that
we study a case where viral growth is limited by the immune
response, not by resource availability (indeed, only a fraction of the
total amount of liver cells seem to be infected, [77]). Moreover, the
half-life of free viruses has been shown to be low [51], which
supports the assumption that these dynamics can be considered to
be at equilibrium. Mathematically, if we denote the number of
cells infected by viral strain i by xi and the number of T-cells of
type j by yj, the population dynamics are governed by the
following system of nzm equations:
dxi
dt
~ Qi{
X m
j~1
sijyj{dx
 !
xi ð1aÞ
dyj
dt
~
X n
i~1
cijQixi{dy
 !
yj ð1bÞ
where Qi is what we refer to as the replication rate of strain i (it
corresponds to the rate at which viruses of strain i are produced
and infect susceptible cells), dx is the base-line death rate of
infected cells, sij is the killing rate of cells infected by viruses of
strain i by lymphocytes of clone j, cij is the activation rate of
lymphocytes of clone j by cells infected by viral strain i and dy is
the lymphocyte death rate (the notations used are summarised in
Table 1). As in Alizon [7], the immune activation term does not
only depend on the number of infected cells (xi) but on the overall
viral growth rate (Qixi, see Introduction).
T-cells of clone j are defined by one trait that does not vary over
time: their receptor (Rj). Viruses of strain i are defined by an
antigen value (Ai). In reality, viruses are recognised by cellular
immune responses via multiple antigenic peptides but the
combination of peptides is unique and it is this combination that
our antigen value reflects. For simplicity and to avoid boundary
effects, the receptor and antigen values are chosen on a finite
space, i.e. in 0,2p ½  . The intensity of the cross-reactivity between a
lymphocyte clone and a viral strain depends on a measure of the
genetic proximity, i.e. Ai{Rj
       . The strength of the cross-
immunity between an antigen Ai and a receptor Rj is then given
by a 2p-periodic function. More precisely, we have
cij~cmax cos
Ai{Rj
2
          
       
1
q
ð2aÞ
sij~smax cos
Ai{Rj
2
          
       
1
q
ð2bÞ
where q is the width (or breadth) of the cross-reactive immunity
and cmax and smax are the maximum values for cij and sij,
respectively. We assume that cross-reactivity affects both the T-cell
proliferation and the killing of infected cells. Here, increasing q
results in an increase in the range of antigen values Ai recognised
by receptor Rj. Note that the cross-immunity function has a
maximum for Ai~Rj. Note also that in the model as we define it
in equation system 1, a viral strain undergoes immune killing by all
the lymphocyte clones (but with variable efficiency), which means
there is never complete immune escape. For further details on
modelling cross-immunity as a function of the distance between
antigens and receptors, see [8] and the discussion therein.
Evolutionary dynamics
Equation system 1 only describes within-host dynamics, but
nothing is specified concerning evolutionary processes. Here, the
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infected cells can mutate to a new viral strain with probability m.
Mutations are modelled as stochastic events following a Binomial
distribution (for details see Text S1).
In this model, viruses of strain i are defined by two traits, their
replication rate (Qi) and their antigen (Ai). Each time a virus
replicates within a cell, it produces ‘mutants’, i.e. offspring with
different genomes. Mutations in the genome sequence can be
silent or affect the phenotype of the virus, and then can be
deleterious or advantageous. Here, we consider mutations
affecting both the antigen and the replication rate of a virus.
Therefore, our mutation event is a composite event that accounts
for mutations leading to a new replication rate and to a change in
the antigenic value.
We analyse the effect of escape mutants with a hybrid
stochastic-deterministic approach (see Text S1), where the
population dynamics of the strains are given by equation system
1. A mutant strain is defined, as any other strain, by its antigen
value and its replication rate. The antigen is drawn randomly
among one of the Amax~1000 possible values (see above). By
doing so, we allow for the mutant to (partially) evade the existing
immune response while limiting the impact of the antigen value on
viral evolution. The mutant replication rate depends on that of the
original strain. There is little data on the shape of the distribution
in which the trait value of a new mutant should be drawn, even if
there are strong constraints on RNA genomes [78]. Without
further information, we assume for simplicity that the replication
rate of the new strain is drawn from a uniform distribution of
width w centred at the replication rate value of the original strain.
We assume a finite number of replication rates Rmax that is fixed
to 100 in the default case.
We wish to stress that our model allows for backwards mutation.
By this we mean that a mutant can be identical to another strain in
the infection or to a strain that was present earlier in the infection.
This approach provides a realistic representation of the quasi-
species characteristics of HCV evolution and frees us from
potential biases due to infinite allele model assumptions.
The number of strains is not constant in these simulations. We
follow the evolution of strain diversity by measuring the Shannon
index,
Dt ðÞ ~{
X n
i~1
xi t ðÞ
Xt ðÞ
log
xi t ðÞ
Xt ðÞ
  
ð3Þ
where X(t) is the total density of infected cells at time t, i.e.
Xt ðÞ ~
P
i xi t ðÞ . The higher the value of D, the more diverse the
infection is.
We extended the model to study the effect of two types of
treatments. The first type of treatment directly increases the killing
of infected cells. It is obtained by adding a death term ({t1xi)i n
equation 1a, where t1 is the treatment efficiency rate. The second
type of treatment blocks viral replication. This is modelled by
multiplying the Qi by 1{t2 ðÞ in equations 1a and b, where t2 is
the treatment efficiency in reducing viral replication. Treatment
efficiencies are assumed not to vary among strains. Further
details concerning the model with treatments can be found in the
Text S1.
We do not introduce host death in the default case of the model.
The main justification for this assumption is that, from the point of
view of the virus, host recovery or host death are very similar, the
only difference lies at the epidemiological level that is outside the
scope of this study. The effect of virulence is shown in Text S2. We
also investigated the effects of a saturation term in the lymphocyte
proliferation rate due to resource competition. This term does not
change qualitatively the results presented (see Text S2).
Evolutionary epidemiology
Having a nested model requires a careful definition of the viral
trait that evolves at the between-host level. Here, we follow the
replication rate of the strain that causes an infection (or ‘initial
replication rate’). Can this trait evolve under natural selection at
the between-host level? For this, three conditions must be fulfilled
[79]: the trait value must be variable in the population, it must be
heritable (here from one infection to the next) and it must have a
fitness effect. The first condition is fulfilled because viral
replication rates are known to vary among infections (see the
Background section). The validity of the last two conditions is
unknown: so far, no data show that the initial replication rate is
heritable from one infection to the next, nor that it has an effect on
the infection fitness. Our model allows us to test if these two
conditions are fulfilled. If so, we can identify trait values that are
optimal at the between-host level.
Now that we have specified our trait of interest, we need to
introduce a fitness measure for the infection bearing the trait. The
‘fitness’ of an infection can be expressed through the basic
reproduction ratio (R0), which indicates the number of new
infections caused by an infected host in a population of susceptible
hosts [9]. This R0 is a measure of the invasion fitness and, as
discussed in [70], it can be used to study disease evolution
provided that the epidemiological dynamics are simple (for
instance there should not be frequency-dependent feedbacks).
To estimate the infection fitness, we introduce a random
transmission event in the simulation. At each time step, this event
occurs with a probability proportional to the log of the total
density of infected cells at this time, thus reflecting recent data
showing that the transmission rate during primary infections with
HIV increases linearly or more than linearly with the viral load
[80] (for further details, see Text S1). The trait of the transmitted
strain depends on the proportion of each type of strain at the time
the transmission event takes place. We use the number of
transmission events during an infection to estimate infection
fitness. (This number correlates with the total number of viruses
produced during an infection.) We also have access to the average
replication rate of transmitted strains as a function of the initial
replication rate, which allows us to assess the heritability, from one
infection to the next, of the trait of interest.
In addition to the infection fitness, we investigate the effect of
parameter values and initial values on several life-history traits of
the infection: the duration of the infection, the final viral diversity
(measured near the end of the infection), the final total immune
cell density, and the final total viral load. The analysis is performed
by varying one of the parameters at the time and running
simulations for 22 different initial replication rates (ranging from
0:005 to 2day{1). In order to keep the computational time within
feasible time scales, we introduce a maximum duration of an
infection of 800 days (2 years circa), which is sufficiently long to
represent a chronic infection. An additional reason not to prolong
in silico infections beyond 800 days is that long-lasting infections
are characterised by impaired immune responses, where the HCV
directed immune responses undergo a functional change [21],
which would call for a different modelling approach. To test the
robustness of our results, we run each simulation setting 200 times
(see also Text S1 for more details of the simulations).
Finally, we introduce a weighted average replication rate of
transmitted strains. The rationale for this is that the average
replication rate of transmitted strains per se is not sufficient to
estimate the long-term fitness. For instance, in a very extreme case
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infected host and where the infection fitness of strain A would be
close to 0, it is easy to see that in the long term strain B should be
more frequent than strain A. In other words, if one of the
transmitted strains generates an infection with negligible infection
fitness, it will not contribute to shaping the virus population in the
long term. If the infection fitness of an infection caused by a strain
with replication rate Qi is denoted W Qi ðÞ , the weighted average
replication rate is given by
X
j[T
W Qj
  
Qj
P
i[T
W Qi ðÞ
ð4Þ
where T is the set containing all the strains transmitted from the
host. Note that in the classical average, the weights W Qj
     
are
assumed to be equal to 1. Similar methods, such as weighting the
contribution of the transmitted viruses with their relative value of
fitness at the next generation, are often adopted in evolutionary
biology in kin selection models, where the fitness gain obtained by
an individual through its offspring (in terms of inclusive fitness) has
to be weighted by the reproductive value of the offspring [81].
Supporting Information
Figure S1 Dynamics of the average replication rate of
transmitted strains and of the total number of strains transmitted
per day We show the results obtained for 200 simulation runs for
low, average, and high cross-reactive immune responses, respec-
tively (q, indicated on the top of each panel). Other parameter
values are as in Table 1, and Q=0.3. The top panels show the
replication rates transmitted over time (red dots), and the solid line
represent the result of linear regression (A) r
2=0.902, B)
r
2=0.883, C) r
2=0.810). Bottom panels show the number of
transmission events over time. Increasing cross-reactive immunity
(from left to right) decreases the average replication rate of
transmitted strains.
Found at: doi:10.1371/journal.pcbi.1000565.s001 (0.16 MB TIF)
Figure S2 Effects of parameter variations on the replication rate
of transmitted strains. Effect of the initial replication rate Q0 (x-
axis) on the average transmitted replication rate for different values
of A) mutation rate m, B) mutation width w of the replication rate,
C) maximum proliferation rate of immune cells cmax, and D)
maximum killing rate of immune cells smax. Different parameter
values are shown using different colour symbols (see the box in
each panel) and the default case is in black.
Found at: doi:10.1371/journal.pcbi.1000565.s002 (0.52 MB EPS)
Text S1 Details about the simulations. This text file gives further
details about the simulations and the statistical tests used in
Table 2.
Found at: doi:10.1371/journal.pcbi.1000565.s003 (0.08 MB PDF)
Text S2 Additional results. We discuss the effect on life-history
traits of variations of the initial value of immune cells and infected
cells, of the probability of virulence and of the effect of a saturation
term for the description of lymphocyte proliferation rate function.
Found at: doi:10.1371/journal.pcbi.1000565.s004 (0.08 MB PDF)
Acknowledgments
We thank T. Day, A. Lloyd, N. Mideo, S. Lion, S. Gandon, A. Zecry, and
two anonymous reviewers for helpful comments.
Author Contributions
Conceived and designed the experiments: FL SA. Performed the
experiments: FL SA. Analyzed the data: FL SA. Contributed reagents/
materials/analysis tools: FL SA. Wrote the paper: FL SA.
References
1. Sasaki A, Iwasa Y (1991) Optimal growth schedule of pathogens within a host:
Switching between lytic and latent cycles. Theor Popul Biol 39: 201–239.
2. Antia R, Levin BR, May RM (1994) Within-host population dynamics and
the evolution and maintenance of microparasite virulence. Am Nat 144: 457–
472.
3. Gilchrist MA, Sasaki A (2002) Modeling host-parasite coevolution: a nested
approach based on mechanistic models. J Theor Biol 218: 289–308.
4. Andre ´ JB, Ferdy JB, Godelle B (2003) Within-host parasite dynamics, emerging
trade-off, and evolution of virulence with immune system. Evolution 57(7):
1489–1497.
5. Alizon S, van Baalen M (2005) Emergence of a convex trade-off between
transmission and virulence. Am Nat 165: E155–E167.
6. Coombs D, Gilchrist MA, Ball CL (2007) Evaluating the importance of within-
and between-host selection pressures on the evolution of chronic pathogens.
Theor Popul Biol 72: 576–591.
7. Alizon S (2008) Transmission-recovery trade-offs to study parasite evolution. Am
Nat 172: E113–E121.
8. Alizon S, van Baalen M (2008) Multiple infections, immune dynamics and
virulence evolution. Am Nat 172: E150–E158.
9. Anderson RM, May RM (1991) Infectious Diseases of Humans. Dynamics and
Control. Oxford: Oxford University Press.
10. Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, et al. (1985)
The quasispecies (extremely heterogeneous) nature of viral RNA genome
populations: biological relevance–a review. Gene 40: 1–8.
11. Nowak MA, May RM, Anderson RM (1990) The evolutionary dynamics of
HIV-1 quasispecies and the development of immunodeficiency disease. AIDS 4:
1095–1103.
12. De Boer RJ, Boerlijst MC (1994) Diversity and Virulence Thresholds in AIDS.
Proc Natl Acad Sci USA 91: 544–548.
13. Williamson S (2003) Adaptation in the env gene of HIV-1 and evolutionary
theories of disease progression. Mol Biol Evol 20: 1318–1325.
14. Shriner D, Liu Y, Nickle DC, Mullins JI (2006) Evolution of intrahost HIV-1
genetic diversity during chronic infection. Evolution 60: 1165–1176.
15. Rambaut A, Posada D, Crandall KA, Holmes EC (2004) The causes and
consequences of HIV evolution. Nat Rev Genet 5: 52–61.
16. Troyer RM, Collins KR, Abraha A, Fraundorf E, Moore DM, et al. (2005)
Changes in human immunodeficiency virus type 1 fitness and genetic diversity
during disease progression. J Virol 79: 9006–9018.
17. Arie ¨n KK, Vanham G, Arts EJ (2007) Is HIV-1 evolving to a less virulent form
in humans? Nat Rev Microbiol 5: 141–151.
18. Luo G, Hamatake RK, Mathis DM, Racela J, Rigat KL, et al. (2000) De novo
initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of
hepatitis C virus. J Virol 74: 851–863.
19. Drake JW, Charlesworth B, Charlesworth D, Crow JF (1998) Rates of
spontaneous mutation. Genetics 148: 1667–1686.
20. Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus–15 years
on. J Gen Virol 85: 3173–3188.
21. Bowen DG, Walker CM (2005) Mutational escape from CD8+ T cell immunity:
HCV evolution, from chimpanzees to man. J Exp Med 201: 1709–1714.
22. Bremermann HJ, Pickering J (1983) A game-theoretical model of parasite
virulence. J Theor Biol 100: 411–426.
23. Levin BR, Bull JJ (1994) Short-sighted evolution and the virulence of pathogenic
microorganisms. Trends Microbiol 2: 76–81.
24. de Roode JC, Pansini R, Cheesman SJ, Helinski MEH, Huijben S, et al. (2005)
Virulence and competitive ability in genetically diverse malaria infections. Proc
Natl Acad Sci USA 102: 7624–7628.
25. Bonhoeffer S, Nowak MA (1994) Mutation and the evolution of virulence.
Proc R Soc Lond B 258: 133–140.
26. van Baalen M, Sabelis MW (1995) The dynamics of multiple infection and the
evolution of virulence. Am Nat 146: 881–910.
27. Frank SA (1996) Models of parasite virulence. Q Rev Biol 71: 37–78.
28. Regoes RR, Wodarz D, Nowak MA (1998) Virus dynamics: the effect of target
cell limitation and immune responses on virus evolution. J theor Biol 191:
451–462.
29. Iwasa Y, Michor F, Nowak MA (2005) Virus evolution within patients increases
pathogenicity. J Theor Biol 232: 17–26.
HCV Evolution within and between Hosts
PLoS Computational Biology | www.ploscompbiol.org 13 November 2009 | Volume 5 | Issue 11 | e100056530. Andre ´ JB, Godelle B (2006) Within-host evolution and virulence in
microparasites. J Theor Biol 241: 402–409.
31. Nelson GW, Perelson AS (1992) A mechanism of immune escape by slow-
replicating HIV strains. J Acquir Immune Defic Syndr 5: 82–93.
32. Gilchrist MA, Coombs D, Perelson AS (2004) Optimizing within-host viral
fitness: infected cell lifespan and virion production rate. J Theor Biol 229:
281–288.
33. Almogy G, Cohen N, Sto ¨cker S, Stone L (2002) Immune response and virus
population composition: HIV as a case study. Proc R Soc Lond B 269: 809–815.
34. Ball CL, Gilchrist MA, Coombs D (2007) Modeling within-host evolution of
HIV: mutation, competition and strain replacement. Bull Math Biol 69:
2361–2385.
35. Alizon S (2009) The Price equation framework to study disease within-host
evolution. J Evol Biol 22: 1123–1132.
36. Overbaugh J, Bangham CR (2001) Selection forces and constraints on retroviral
sequence variation. Science 292: 1106–1109.
37. Nowak MA, May RM (2000) Virus dynamics: Mathematical principles of
immunology and virology. Oxford, USA: Oxford University Press.
38. Alizon S, van Baalen M (2008) Acute or chronic? Within-host models with
immune dynamics, infection outcome and parasite evolution. Am Nat 172:
E244–E256.
39. Pradeu T, Carosella E (2006) The self model and the conception of biological
identity in immunology. Biol Philos 21: 235–252.
40. Yewdell JW (2007) Plumbing the sources of endogenous MHC class I peptide
ligands. Curr Opin Immunol 19: 79–86.
41. Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, et al. (2003)
Quantitating protein synthesis, degradation, and endogenous antigen processing.
Immunity 18: 343–354.
42. Bocharov G, Ludewig B, Bertoletti A, Klenerman P, Junt T, et al. (2004)
Underwhelming the immune response: effect of slow virus growth on CD8
+-T-
lymphocyte responses. J Virol 78: 2247–2254.
43. Albaghdadi H, Robinson N, Finlay B, Krishnan L, Sad S (2009) Selectively
reduced intracellular proliferation of Salmonella enterica serovar typhimurium
within APCs limits antigen presentation and development of a rapid CD8 T cell
response. J Immunol 183: 3778–87.
44. Zinkernagel RM, Hengartner H (2001) Regulation of the immune response by
antigen. Science 293: 251–253.
45. Cox AL, Mosbruger T, Lauer GM, Pardoll D, Thomas DL, et al. (2005)
Comprehensive analyses of CD8+ T cell responses during longitudinal study of
acute human hepatitis C. Hepatology 42: 104–12.
46. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, et al. (2002)
Viral and immunological determinants of hepatitis C virus clearance,
persistence, and disease. Proc Natl Acad Sci USA 99: 15661–15668.
47. Thimme R, Oldach D, Chang KM, Steiger C, Ray SCea (2001) Determinants
of viral clearance and persistence during acute hepatitis C virus infection. J Exp
Med 194: 1395–1406.
48. Shin EC, Capone S, Cortese R, Colloca S, NicosiaAea (2008) The kinetics of
hepatitis C virus-specific CD8 T-cell responses in the blood mirror those in the
liver in acute hepatitis C virus infection. J Virol 82: 9782–9788.
49. Sentandreu V, Jime ´nez-Herna ´ndez N, Torres-Puente M, Bracho MA, Valero A,
et al. (2008) Evidence of recombination in intrapatient populations of hepatitis C
virus. PLoS ONE 3: e3239.
50. Maynard Smith J (1982) Evolution and the theory of games. Cambridge:
Cambridge University Press.
51. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, et al. (1998)
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha
therapy. Science 282: 103–107.
52. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams Rea (2000) Hepatitis C
virus-specific T-cell reactivity during interferon and ribavirin treatment in
chronic hepatitis C. Gastroenterology 118: 346–355.
53. Kamal SM, Fehr J, Roesler B, Peters T, Rasenack JW (2002) Gastroenterology.
Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1
responses in patients with chronic hepatitis C 123: 1070–1083.
54. Fraser C, Hollingsworth TD, Chapman R, de Wolf F, Hanage WP (2007)
Variation in HIV-1 set-point viral load: epidemiological analysis and an
evolutionary hypothesis. Proc Natl Acad Sci USA 104: 17441–17446.
55. Ewald PW (1994) Evolution of Infectious Disease. Oxford: Oxford University
Press.
56. Alizon S, Hurford A, Mideo N, van Baalen M (2009) Virulence evolution and
the trade-off hypothesis: history, current state of affairs and the future. J Evol
Biol 22: 245–259.
57. Van Baalen M (1998) Coevolution of recovery ability and virulence. Proc R Soc
Lond B 265: 317–325.
58. Gandon S, Mackinnon MJ, Nee S, Read AF (2001) Imperfect vaccines and the
evolution of pathogen virulence. Nature 414: 751–756.
59. Mackinnon MJ, Read AF (2004) Immunity promotes virulence evolution in a
malaria model. PLoS Biol 2: 1286–1292.
60. Wodarz D (2003) Hepatitis C virus dynamics and pathology: the role of CTL
and antibody responses. J Gen Virol 84: 1743–1750.
61. Stumpf MPH, Pybus OG (2002) Genetic diversity and models of viral evolution
for the hepatitis C virus. FEMS Microbiol Lett 214: 143–152.
62. Sheridan I, Pybus OG, Holmes EC, Klenerman P (2004) High-resolution
phylogenetic analysis of hepatitis C virus adaptation and its relationship to
disease progression. J Virol 78: 3447–3454.
63. Virgin HW, Wherry EJ, Ahmed R (2009) Redefining chronic viral infection.
Cell 138: 30–50.
64. Farci P, Munoz SJ, Shimoda A, Govindarajan S, Wong DC, et al. (1999)
Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a
chimpanzee. J Infect Dis 179: 1007–1011.
65. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, et al. (2000) The outcome of
acute hepatitis C predicted by the evolution of the viral quasispecies. Science
288: 339–344.
66. Weiner AJ, Paliard X, Selby MJ, Medina-Selby A, Coit D, et al. (2001)
Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-
protective immunity. J Virol 75: 7142–7148.
67. Mas A, Ulloa E, Bruguera M, Furcic I, Garriga D, et al. (2004) Hepatitis C virus
population analysis of a single-source nosocomial outbreak reveals an inverse
correlation between viral load and quasispecies complexity. J Gen Virol 85:
3619–3626.
68. Dustin LB, Rice CM (2007) Flying under the radar: the immunobiology of
hepatitis c. Annu Rev Immunol 25: 71–99.
69. Yerly D, Heckerman D, Allen TM, Chisholm III JV, Faircloth K, et al. (2008)
Increased cytotoxic T-lymphocyte epitope variant cross-recognition and
functional avidity are associated with hepatitis C virus clearance. J Virol 82:
3147–3153.
70. Dieckmann U (2002) Adaptive dynamics of pathogen-host interactions. In:
Dieckmann U, Metz JAJ, Sabelis MW, Sigmund K, eds. Adaptive dynamics of
infectious diseases: In pursuit of virulence management Cambridge University
Press. pp 39–59.
71. Day T (2001) Parasite transmission modes and the evolution of virulence.
Evolution 55: 2389–2400.
72. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008)
Identification and characterization of transmitted and early founder virus
envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 105:
7552–7557.
73. Timm J (2004) CD8 epitope escape and reversion in acute HCV infection. J Exp
Med 200: 1593–1604.
74. Yerly D, Heckerman D, Allen T, Suscovich TJ, Jojic N, et al. (2008) Design,
expression, and processing of epitomized hepatitis C virus-encoded CTL
epitopes. J Immunol 181: 6361–70.
75. Nielsen M, Lundegaard C, Blicher T, Peters B, Sette A, et al. (2008)
Quantitative predictions of peptide binding to any HLA-DR molecule of known
sequence: NetMHCIIpan. PLoS Comput Biol 4: e1000107.
76. Lundegaard C, Lund O, Kesmir C, Brunak S, Nielsen M (2007) Modeling the
adaptive immune system: predictions and simulations. Bioinformatics 23:
3265–3275.
77. Agnello V, Abel G, Knight GB, Muchmore E (1998) Detection of widespread
hepatocyte infection in chronic hepatitis C. Hepatology 28: 573–584.
78. Belshaw R, Gardner A, Rambaut A, Pybus OG (2008) Pacing a small cage:
mutation and RNA viruses. Trends Ecol Evol 23: 188–193.
79. Lewontin RC (1970) The units of selection. Annu Rev Ecol Syst 1: 1–18.
80. Hollingsworth TD, Anderson RM, Fraser C (2008) HIV-1 transmission, by stage
of infection. J Infect Dis 198: 687–693.
81. Taylor PD (1992) Altruism in viscous populations – an inclusive fitness model.
Evol Ecol 6: 352–356.
82. Muller V, Mare ´e AFM, De Boer RJ (2001) Small variations in multiple
parameters account for wide variations in HIV-1 set-points: a novel modelling
approach. Proc R Soc Lond B 268: 235–242.
83. Dahari H, Layden-Almer JE, Kallwitz E, Ribeiro RM, Cotler SJ, et al. (2009) A
mathematical model of hepatitis C virus dynamics in patients with high baseline
viral loads or advanced liver disease. Gastroenterology 136: 1402–1409.
HCV Evolution within and between Hosts
PLoS Computational Biology | www.ploscompbiol.org 14 November 2009 | Volume 5 | Issue 11 | e1000565